Moreover, metabolic disorders such as T2DM, obesity, and hypertension are directly associated with increased DPPIV activity, which, in turn, is associated with the severity of COVID-19 and its complications [74]. The gene discussed is DPP4; the disease is obesity due to melanocortin 4 receptor deficiency.